Skip to content
Zydus Lifesciences
-
Zydus Lifesciences to acquire Assertio Holdings in US$166.4M deal to expand US oncology portfolio
The acquisition will give Zydus access to Assertio’s commercial infrastructure in the US specialty pharmaceutical market, particularly in oncology supportive care and pain management therapies.
-
Agenus signs USD141M partnership with Zydus Lifesciences to advance cancer immunotherapy program
This collaboration delivers crucial funding to Agenus while simultaneously securing sustained biologics manufacturing capacity within the United States.